CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications

Jennifer L. St Sauver, Janet E. Olson, Veronique L. Roger, Wayne T. Nicholson, John L. Black, Paul Y. Takahashi, Pedro J. Caraballo, Elizabeth J. Bell, Debra J. Jacobson, Nicholas B. Larson, Suzette J. Bielinski

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications'. Together they form a unique fingerprint.

Medicine & Life Sciences